NCT04349995View on ClinicalTrials.gov

Amplatzer PFO Occluder Post-marketing Surveillance Study

Active, not recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

December 14, 2022

Study Completion Date

May 28, 2026

Conditions
PFO - Patent Foramen Ovale
Interventions
DEVICE

Amplatzer PFO Occluder

Percutaneous PFO closure using Amplatzer PFO Occluder

Trial Locations (1)

108-6304

Abbott Medical Japan LLC, Mita

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT04349995 - Amplatzer PFO Occluder Post-marketing Surveillance Study | Biotech Hunter | Biotech Hunter